| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CENBF | Common Stock | 3,030,000 | 09 Jul 2021 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Lawrence Lehoux (the "Reporting Person") was appointed to his positions with CEN Biotech, Inc. (the "Issuer") on July 9, 2021 and owned 3,030,000 shares of the Issuer's common stock at such date. |